Cover Image
Market Research Report

U.S. Market for Interventional Cardiology Devices

Published by iData Research Inc. Product code 333112
Published Content info 1004 Pages
Delivery time: 1-2 business days
Back to Top
U.S. Market for Interventional Cardiology Devices
Published: February 12, 2018 Content info: 1004 Pages

Interventional Cardiology Devices Market - US:
Units Sold, Average Selling Prices, Procedure Volumes, Market Values, Shares, Product Pipeline, Forecasts, SWOT - Coronary Stents, Coronary Balloon Catheters, Balloon-Inflation Devices, Interventional Coronary Catheters, Interventional Coronary Guidewires, Coronary Embolic Protection Devices, Coronary Atherectomy Devices, Coronary Thrombectomy Devices, Coronary Chronic Total Occlusion System, Introducer Sheaths, Coronary Vascular Closure Devices, Diagnostic Coronary Catheters and Guidewires, Intravascular Ultrasound, Optical Coherence Tomography: 2018-2024.


The total market value includes a large number of segments such as the coronary stent, coronary balloon catheter, balloon-inflation device, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, coronary atherectomy device, coronary thrombectomy device, chronic total occlusion system, introducer sheath, coronary vascular closure device, diagnostic coronary catheter and guidewire, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) markets.

While this report suite contains all US interventional cardiology device data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the interventional cardiology market research that you need. You can view all these included reports and segmentation here:

  • Interventional Cardiology Device Market Overview for US 2018 - MedView - Gives an easily accessible view of all interventional cardiology device markets and trends and aggregates the data together for a picture of the total US market.
  • Procedure Volumes for Interventional Cardiology for US 2018 - MedPro - Using a number of databases, internal and external, we're able to provide you with the total volume of interventional cardiology procedures being performed for each of the markets mentioned in this suite of reports.
  • Coronary Stent Market for US 2018 - MedCore - Covers segmentation into Bare-Metal Stents, Drug-Eluting Stents, Covered Stents, Bifurcated Stents, and Bioresorbable Stents.
  • Coronary Balloon Catheter Market for US 2018 - MedCore - Segmented into 2 main markets, PTCA Balloon Catheters and Specialty Balloon Catheters.
  • Balloon-Inflation Device Market for US 2018 - MedCore - The primary uses of balloon-inflation devices are to inflate dilation balloons for stent placement as well as to inject contrast agents for use in diagnostic procedures.
  • Interventional Coronary Catheter Market for US 2018 - MedCore - Interventional catheters are used by physicians in procedures for the placement of devices such as stents and balloons.
  • Interventional Coronary Guidewire Market for US 2018 - MedCore - Interventional guidewires used for coronary applications can be classified into two general types: conventional and specialty guidewires.
  • Coronary Embolic Protection Device Market for US 2018 - MedCore - Embolic protection devices (EPDs) are used to mechanically capture or aspirate the plaque which may be dislodged during an interventional coronary procedure and create health risks for the patient.
  • Coronary Atherectomy Device Market for US 2018 - MedCore - Further segmented into Mechanical Atherectomy and Laser Atherectomy Device Markets.
  • Coronary Thrombectomy Device Market for US 2018 - MedCore - Intravascular catheters are used to remove or aspirate obstructing particles from the bloodstream in a thrombectomy procedure.
  • Coronary Chronic Total Occlusion System Market for US 2018 - MedCore - This market report is segmented into 3 markets: Guidewires, Catheters, and Devices.
  • Introducer Sheath Market for US 2018- MedCore - Segmented into Standard Introducer Sheaths and Micro-Introducer Sheaths.
  • Coronary Vascular Closure Device Market for US 2018 - MedCore - Covers 2 primary markets, Invasive and Non-Invasive Coronary Vascular Closure Devices.
  • Diagnostic Coronary Catheter and Guidewire Market for US 2018 - MedCore - Includes segmentation on Diagnostic Coronary Catheters and Guidewires, as well as Fractional Flow Reserve Guidewires.
  • Intravascular Ultrasound Market for US 2018 - MedCore - Further segmented into Intravascular Ultrasound Catheters and Intravascular Ultrasound Consoles.
  • Optical Coherence Tomography Market for US 2018 - MedCore - This report covers segmentation on both Optical Coherence Tomography Catheters and Consoles.
  • OTHER INFORMATION - Company Profiles and SWOT, Disease Overviews, & Related Press Releases from Top Competitors

Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More


Similar to other medical device markets, the interventional cardiology market been experiencing a period of consolidation in recent years. Large competitors are either entering the overall market or expanding their reach by entering new segments through strategic mergers and acquisitions. One trend that has risen as a result of consolidation is the bundling of devices at a discount. Bundling is driven by unfavorable reimbursement conditions and larger competitors who have a wide variety of devices to offer across the interventional cardiology market and are able to negotiate more cost-effective contracts with hospitals and labs. As a result competitive pressure is expected to contribute to declines in prices across the majority of segments in the market.


  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2024, and Historical Data to 2014
  • Market Drivers & Limiters for Each Interventional Cardiology Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Interventional Cardiology Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors


Of the many companies in the interventional cardiology market, Boston Scientific holds the leading position, with Abbott Laboratories and Medtronic following closely behind. Boston Scientific is an extremely well established competitor in the interventional cardiology field, with a strong reputation and large sales force in both the coronary and peripheral markets. The company has recently emphasized its focus on the complex PCI opportunity in the market, for which it offers specialized devices such as CTO systems, atherectomy devices, specialty balloon catheters, embolic protection devices, IVUS and FFR. The company is expected to maintain its leading position in the market.

In this report suite we've analyzed several other companies, which include market shares from Philips, Terumo, Cardinal Health, and Others.


We've been doing market research for medical devices for over a decade. We specialize in it, and the interventional cardiology market was one of our original reports that helped build trust in our research and methodology. We have built relationships with the top competitors in the interventional cardiology market so that we can gather first-hand information in confidence to assure more accurate research - that our partners and clients then benefit from.

Because we're a third party researcher, we have the ability to reach well into the top interventional cardiology companies and look at a multi-angle approach to our research. Not only do we consider financial filings, we conduct interviews, use hospital and procedural databases, and our own history of research to create a picture of the market that's incredibly accurate.

Our clients have used our interventional cardiology market research for years to strategize new markets to break into, submit SEC filings, decide sales and marketing strategies, plan acquisitions and product launches, and provide a 3rd party source to show investors, boards, and senior executives.

Back to Top